UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Is mesalazine treatment effective in the prevention of diverticulitis? A review

European review for medical and pharmacological sciences, 2020-08, Vol.24 (15), p.8164

2020

Volltextzugriff (PDF)

Infliximab in spondyloarthropathy associated with Crohn’s disease: an open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut manifestations

Annals of the rheumatic diseases, 2004-12, Vol.63 (12), p.1664-1669

2004

Volltextzugriff (PDF)

P.09.11 ASSOCIATION BETWEEN COLORECTAL POLYPS AND COLONIC DIVERTICULOSIS

Digestive and liver disease, 2016-02, Vol.48, p.e175-e175

2016

Volltextzugriff (PDF)

The dyspeptic macrophage 30 years later: An update in the pathogenesis of Crohn's disease

Digestive and liver disease, 2009-02, Vol.41 (2), p.166-168

2009

Volltextzugriff (PDF)

Boswellia serrata and Salvia miltiorrhiza extracts reduce DMN-induced hepatic fibrosis in mice by TGF-beta1 downregulation

European review for medical and pharmacological sciences, 2012-10, Vol.16 (11), p.1484

2012

Volltextzugriff (PDF)

Mucosal 5-aminosalicylic acid concentration inversely correlates with severity of colonic inflammation in patients with ulcerative colitis

Gut, 2000-09, Vol.47 (3), p.410-414

2000

Volltextzugriff (PDF)

P.06.6 SUBTYPES OF CHRONIC GASTRITIS IN PATIENTS WITH COELIAC DISEASE BEFORE AND AFTER GLUTEN-FREE DIET

Digestive and liver disease, 2016-02, Vol.48, p.e155-e155

2016

Volltextzugriff (PDF)

P.03.10 FUNCTIONAL DYSPEPSIA: IS DUODENAL BIOPSY WORTHWHILE?

Digestive and liver disease, 2014-03, Vol.46, p.S63-S63

2014

Volltextzugriff (PDF)

Long-term oral plus topical mesalazine in frequently relapsing ulcerative colitis

Digestive and liver disease, 2005-02, Vol.37 (2), p.92-96

2005

Volltextzugriff (PDF)

Mesalazine vanishing time from rectal mucosa following its topical administration

Journal of Crohn's and colitis, 2010-02, Vol.4 (1), p.102-105

2010

Volltextzugriff (PDF)

P.05.12 COLONIC MUCOSAL ORGAN CULTURE: ITS OPPORTUNISTIC USE TO DETECT CELIAC DISEASE

Digestive and liver disease, 2013-03, Vol.45, p.S122-S123

2013

Volltextzugriff (PDF)

Short‐chain fatty acid topical treatment in distal ulcerative colitis

Alimentary pharmacology & therapeutics, 1995-06, Vol.9 (3), p.309-313

1995

Volltextzugriff (PDF)

AF.41 THE PROGNOSTIC VALUE OF ENDOSCOPIC MAYO SCORE 0 VERSUS 1 IN PATIENTS WITH ULCERATIVE COLITIS IN STEROID-FREE CLINICAL REMISSION: A SYSTEMATIC REVIEW AND METAANALYSIS

Digestive and liver disease, 2021-09, Vol.53, p.S155-S156

2021

Volltextzugriff (PDF)

Assessment of inflammatory activity in Crohn's disease by means of dynamic contrast-enhanced MRI

Radiologia medica, 2007-09, Vol.112 (6), p.798-809

2007

Volltextzugriff (PDF)

P.06.14 ADHERENCE TO ANTI-TUMOR NECROSIS FACTOR ALPHA THERAPIES IN INFLAMMATORY BOWEL DISEASES: EXPERIENCE FROM FOUR REFERRAL ITALIAN CENTERS

Digestive and liver disease, 2012-03, Vol.44, p.S123-S124

2012

Volltextzugriff (PDF)

P.06.15 SAFETY OF ANTI-TNFA THERAPY IN IBD: AN ITALIAN EXPERIENCE

Digestive and liver disease, 2012-03, Vol.44, p.S124-S124

2012

Volltextzugriff (PDF)

Rectal and colonic mesalazine concentration in ulcerative colitis: oral vs. oral plus topical treatment

Alimentary pharmacology & therapeutics, 1999-11, Vol.13 (11), p.1413-1417

1999

Volltextzugriff (PDF)

Has infliximab influenced the course and prognosis of acute severe ulcerative colitis?

Biologics, 2019-01, Vol.13, p.23-31

2019

Volltextzugriff (PDF)

Early acid perception in NERD

Diseases of the esophagus, 2011-02, Vol.24 (2), p.127-130

2011

Volltextzugriff (PDF)

Combined oral sodium butyrate and mesalazine treatment compared to oral mesalazine alone in ulcerative colitis randomized, double-blind, placebo-controlled pilot study

Digestive diseases and sciences, 2000-05, Vol.45 (5), p.976-981

2000

Volltextzugriff (PDF)

P.75 AZATHIOPRINE WITHDRAWAL IN CROHN'S DISEASE: NEVER-ENDING STORY?

Digestive and liver disease, 2010, Vol.42, p.S129-S130

2010

Volltextzugriff (PDF)

P.74 AVAILABLE MEDICAL THERAPIES DO NOT AFFECT DEVELOPMENT OF MAJOR COMPLICATIONS AND NEED FOR SURGERY IN CROHN'S DISEASE: LONG-TERM PROSPECTIVE STUDY ON A POPULATION OF 193 CONSECUTIVE PATIENTS

Digestive and liver disease, 2010, Vol.42, p.S129-S129

2010

Volltextzugriff (PDF)

OC.07.2 BECLOMETASONE DIPROPIONATE AND MESALAZINE ARE EQUALLY EFFECTIVE IN THE TREATMENT OF LYMPHOCYTIC COLITIS

Digestive and liver disease, 2010, Vol.42, p.S87-S87

2010

Volltextzugriff (PDF)

AF.61 PROSPECTIVE, OBSERVATIONAL STUDY OF PROPHYLACTIC VEDOLIZUMAB TREATMENT IN PREVENTING POSTOPERATIVE RECURRENCE (POR) IN HIGH-RISK CROHN’S PATIENTS

Digestive and liver disease, 2021-09, Vol.53, p.S164-S165

2021

Volltextzugriff (PDF)

T04.01.17 USEFULNESS ON INTESTINAL ULTRASOUND IN THE EVALUATION OF COLONIC INFLAMMATION IN PATIENTS WITH

Digestive and liver disease, 2020-10, Vol.52, p.S124

2020

Volltextzugriff (PDF)

1 – 25 von 132

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(120)
Mit Volltextzugriff
(94)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(66)
Life Sciences & Biomedicine
(62)
Science & Technology
(62)
Biological And Medical Sciences
(45)
Medical Sciences
(45)
Male
(41)
Middle Aged
(39)
Female
(38)
Adult
(34)
Gastroenterology & Hepatology
(31)
Aged
(21)
Pharmacology. Drug Treatments
(20)
Gastroenterology And Hepatology
(14)
Gastroenterology. Liver. Pancreas. Abdomen
(13)
Other Diseases. Semiology
(13)
Stomach. Duodenum. Small Intestine. Colon. Rectum. Anus
(12)
Hematology
(11)
Intestinal Mucosa - Metabolism
(9)
Aged, 80 And Over
(8)
Digestive System
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Is mesalazine treatment effective in the prevention of diverticulitis? A review

Infliximab in spondyloarthropathy associated with Crohn’s disease: an open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut manifestations

P.09.11 ASSOCIATION BETWEEN COLORECTAL POLYPS AND COLONIC DIVERTICULOSIS

The dyspeptic macrophage 30 years later: An update in the pathogenesis of Crohn's disease

Boswellia serrata and Salvia miltiorrhiza extracts reduce DMN-induced hepatic fibrosis in mice by TGF-beta1 downregulation

Mucosal 5-aminosalicylic acid concentration inversely correlates with severity of colonic inflammation in patients with ulcerative colitis

P.06.6 SUBTYPES OF CHRONIC GASTRITIS IN PATIENTS WITH COELIAC DISEASE BEFORE AND AFTER GLUTEN-FREE DIET

P.03.10 FUNCTIONAL DYSPEPSIA: IS DUODENAL BIOPSY WORTHWHILE?

Long-term oral plus topical mesalazine in frequently relapsing ulcerative colitis

Mesalazine vanishing time from rectal mucosa following its topical administration

P.05.12 COLONIC MUCOSAL ORGAN CULTURE: ITS OPPORTUNISTIC USE TO DETECT CELIAC DISEASE

Short‐chain fatty acid topical treatment in distal ulcerative colitis

AF.41 THE PROGNOSTIC VALUE OF ENDOSCOPIC MAYO SCORE 0 VERSUS 1 IN PATIENTS WITH ULCERATIVE COLITIS IN STEROID-FREE CLINICAL REMISSION: A SYSTEMATIC REVIEW AND METAANALYSIS

Assessment of inflammatory activity in Crohn's disease by means of dynamic contrast-enhanced MRI

P.06.14 ADHERENCE TO ANTI-TUMOR NECROSIS FACTOR ALPHA THERAPIES IN INFLAMMATORY BOWEL DISEASES: EXPERIENCE FROM FOUR REFERRAL ITALIAN CENTERS

P.06.15 SAFETY OF ANTI-TNFA THERAPY IN IBD: AN ITALIAN EXPERIENCE

Rectal and colonic mesalazine concentration in ulcerative colitis: oral vs. oral plus topical treatment

Has infliximab influenced the course and prognosis of acute severe ulcerative colitis?

Early acid perception in NERD

Combined oral sodium butyrate and mesalazine treatment compared to oral mesalazine alone in ulcerative colitis randomized, double-blind, placebo-controlled pilot study

P.75 AZATHIOPRINE WITHDRAWAL IN CROHN'S DISEASE: NEVER-ENDING STORY?

P.74 AVAILABLE MEDICAL THERAPIES DO NOT AFFECT DEVELOPMENT OF MAJOR COMPLICATIONS AND NEED FOR SURGERY IN CROHN'S DISEASE: LONG-TERM PROSPECTIVE STUDY ON A POPULATION OF 193 CONSECUTIVE PATIENTS

OC.07.2 BECLOMETASONE DIPROPIONATE AND MESALAZINE ARE EQUALLY EFFECTIVE IN THE TREATMENT OF LYMPHOCYTIC COLITIS

AF.61 PROSPECTIVE, OBSERVATIONAL STUDY OF PROPHYLACTIC VEDOLIZUMAB TREATMENT IN PREVENTING POSTOPERATIVE RECURRENCE (POR) IN HIGH-RISK CROHN’S PATIENTS

T04.01.17 USEFULNESS ON INTESTINAL ULTRASOUND IN THE EVALUATION OF COLONIC INFLAMMATION IN PATIENTS WITH

Suchergebnisse filtern